Duchenne Muscular Dystrophy - Pipeline Review, H2 2012 New Report
Duchenne Muscular Dystrophy - Pipeline Review, H2 2012, provides an overview of the Duchenne Muscular Dystrophy therapeutic pipeline. This report provides information on the therapeutic development for Duchenne Muscular Dystrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Duchenne Muscular Dystrophy. 'Duchenne Muscular Dystrophy - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC...
View full press release